123 related articles for article (PubMed ID: 20190808)
21. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C
Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526
[TBL] [Abstract][Full Text] [Related]
22. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1.
Fujimoto N; Sueoka N; Sueoka E; Okabe S; Suganuma M; Harada M; Fujiki H
Int J Oncol; 2002 Jun; 20(6):1233-9. PubMed ID: 12012004
[TBL] [Abstract][Full Text] [Related]
23. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
[TBL] [Abstract][Full Text] [Related]
24. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML
Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887
[TBL] [Abstract][Full Text] [Related]
25. T-cell receptor gamma chain alternate reading frame protein (TARP) expression in prostate cancer cells leads to an increased growth rate and induction of caveolins and amphiregulin.
Wolfgang CD; Essand M; Lee B; Pastan I
Cancer Res; 2001 Nov; 61(22):8122-6. PubMed ID: 11719440
[TBL] [Abstract][Full Text] [Related]
26. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
[TBL] [Abstract][Full Text] [Related]
27. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
[TBL] [Abstract][Full Text] [Related]
28. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
Tang DG; Li L; Chopra DP; Porter AT
Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
[TBL] [Abstract][Full Text] [Related]
29. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
Xu LL; Srikantan V; Sesterhenn IA; Augustus M; Dean R; Moul JW; Carter KC; Srivastava S
J Urol; 2000 Mar; 163(3):972-9. PubMed ID: 10688034
[TBL] [Abstract][Full Text] [Related]
30. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
31. Downstream targets of heterogeneous nuclear ribonucleoprotein A2 mediate cell proliferation.
He Y; Rothnagel JA; Epis MR; Leedman PJ; Smith R
Mol Carcinog; 2009 Feb; 48(2):167-79. PubMed ID: 18680105
[TBL] [Abstract][Full Text] [Related]
32. Human hnRNP protein A1 gene expression. Structural and functional characterization of the promoter.
Biamonti G; Bassi MT; Cartegni L; Mechta F; Buvoli M; Cobianchi F; Riva S
J Mol Biol; 1993 Mar; 230(1):77-89. PubMed ID: 8383772
[TBL] [Abstract][Full Text] [Related]
33. Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer.
Kinoshita H; Shi Y; Sandefur C; Meisner LF; Chang C; Choon A; Reznikoff CR; Bova GS; Friedl A; Jarrard DF
Cancer Res; 2000 Jul; 60(13):3623-30. PubMed ID: 10910077
[TBL] [Abstract][Full Text] [Related]
34. Potential role of annexin A7 in cancers.
Guo C; Liu S; Greenaway F; Sun MZ
Clin Chim Acta; 2013 Aug; 423():83-9. PubMed ID: 23639634
[TBL] [Abstract][Full Text] [Related]
35. Prostate-tumor targeting of gene expression by lentiviral vectors containing elements of the probasin promoter.
Yu D; Jia WW; Gleave ME; Nelson CC; Rennie PS
Prostate; 2004 Jun; 59(4):370-82. PubMed ID: 15065085
[TBL] [Abstract][Full Text] [Related]
36. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.
Jarrard DF; Kinoshita H; Shi Y; Sandefur C; Hoff D; Meisner LF; Chang C; Herman JG; Isaacs WB; Nassif N
Cancer Res; 1998 Dec; 58(23):5310-4. PubMed ID: 9850055
[TBL] [Abstract][Full Text] [Related]
37. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
38. ANXA7-GTPase as Tumor Suppressor: Mechanisms and Therapeutic Opportunities.
Leighton X; Eidelman O; Jozwik C; Pollard HB; Srivastava M
Methods Mol Biol; 2017; 1513():23-35. PubMed ID: 27807828
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of protein profiling by proteomic analysis in camptothecin-resistant PC3 and camptothecin-sensitive LNCaP human prostate cancer cells.
Hasegawa N; Mizutani K; Suzuki T; Deguchi T; Nozawa Y
Urol Int; 2006; 77(4):347-54. PubMed ID: 17135786
[TBL] [Abstract][Full Text] [Related]
40. High ANXA7 Potentiates Eucalyptol Toxicity in Hormone-refractory Prostate Cancer.
Leighton X; Bera A; Eidelman O; Eklund M; Puthillathu N; Pollard HB; Srivastava M
Anticancer Res; 2018 Jul; 38(7):3831-3842. PubMed ID: 29970503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
